NLY-001 shows neuroprotective effect by blocking A1 astrocyte conversion in Parkinson's mice models Aug. 2, 2018
Phase II trial shows no clinical benefit of valproic acid in autosomal dominant retinitis pigmentosa Aug. 2, 2018
RSS